Gleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer

NCT00193349 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Imatinib
DRUG: Irinotecan
DRUG: Carboplatin

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]
[object Object]